{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T06:19:57Z","timestamp":1772086797936,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s00380-024-02438-x","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T16:02:10Z","timestamp":1720540930000},"page":"8-15","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pd\/Pa fluctuation with continuous ATP administration indicates inaccurate FFR measurement caused by insufficient hyperemia"],"prefix":"10.1007","volume":"40","author":[{"given":"Shintaro","family":"Yoneyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Hoyano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyuki","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryutaro","family":"Ikegami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Okubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Yanagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takakuni","family":"Kurokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuzo","family":"Washiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kashimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Inomata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,9]]},"reference":[{"key":"2438_CR1","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1161\/01.CIR.92.11.3183","volume":"92","author":"NH Pijls","year":"1995","unstructured":"Pijls NH, Van Gelder B, Van der Voort P, Peels K, Bracke FA, Bonnier HJ, el Gamal MI (1995) Fractional flow reserve. a useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation 92:3183\u20133193","journal-title":"Circulation"},{"key":"2438_CR2","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1016\/j.jacc.2009.11.096","volume":"55","author":"PA Tonino","year":"2010","unstructured":"Tonino PA, Fearon WF, De Bruyne B, Oldroyd KG, Leesar MA, Ver Lee PN, Maccarthy PA, Van\u2019t Veer M, Pijls NH (2010) Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation. J Am Coll Cardiol 55:2816\u20132821","journal-title":"J Am Coll Cardiol"},{"key":"2438_CR3","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1056\/NEJMoa1205361","volume":"367","author":"B De Bruyne","year":"2012","unstructured":"De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino PA, Piroth Z, Jagic N, M\u00f6bius-Winkler S, Rioufol G, Witt N, Kala P, MacCarthy P, Engstr\u00f6m T, Oldroyd KG, Mavromatis K, Manoharan G, Verlee P, Frobert O, Curzen N, Johnson JB, J\u00fcni P, Fearon WF, FAME 2 Trial Investigators (2012) Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 367:991\u20131001","journal-title":"N Engl J Med"},{"key":"2438_CR4","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1253\/circj.CJ-16-1213","volume":"81","author":"N Tanaka","year":"2017","unstructured":"Tanaka N, Nakamura M, Akasaka T, Kadota K, Uemura S, Amano T, Shiode N, Morino Y, Fujii K, Hikichi Y, CVIT-DEFER Registry Investigators (2017) One-year outcome of fractional flow reserve-based coronary intervention in Japanese daily practice-CVIT-DEFER registry. Circ J 81:1301\u20131306","journal-title":"Circ J"},{"key":"2438_CR5","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.jacc.2016.05.067","volume":"68","author":"GG Toth","year":"2016","unstructured":"Toth GG, Johnson NP, Jeremias A, Pellicano M, Vranckx P, Fearon WF, Barbato E, Kern MJ, Pijls NH, De Bruyne B (2016) Standardization of fractional flow reserve measurements. J Am Coll Cardiol 68:742\u2013753","journal-title":"J Am Coll Cardiol"},{"key":"2438_CR6","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.jcin.2015.01.039","volume":"8","author":"NP Johnson","year":"2015","unstructured":"Johnson NP, Johnson DT, Kirkeeide RL, Berry C, De Bruyne B, Fearon WF, Oldroyd KG, Pijls NHJ, Gould KL (2015) Repeatability of fractional flow reserve despite variations in systemic and coronary hemodynamics. JACC Cardiovasc Interv 8:1018\u20131027","journal-title":"JACC Cardiovasc Interv"},{"key":"2438_CR7","first-page":"580","volume":"26","author":"H Matsumoto","year":"2014","unstructured":"Matsumoto H, Nakatsuma K, Shimada T, Ushimaru S, Mikuri M, Yamazaki T, Matsuda T (2014) Effect of caffeine on intravenous adenosine-induced hyperemia in fractional flow reserve measurement. J Invasive Cardiol 26:580\u2013585","journal-title":"J Invasive Cardiol"},{"key":"2438_CR8","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1161\/01.CIR.82.5.1595","volume":"82","author":"RF Wilson","year":"1990","unstructured":"Wilson RF, Wyche K, Christensen BV, Zimmer S, Laxson DD (1990) Effects of adenosine on human coronary arterial circulation. Circulation 82:1595\u20131606","journal-title":"Circulation"},{"key":"2438_CR9","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/ccd.25305","volume":"84","author":"AH Seto","year":"2014","unstructured":"Seto AH, Tehrani DM, Bharmal MI, Kern MJ (2014) Variations of coronary hemodynamic responses to intravenous adenosine infusion: implications for fractional flow reserve measurements. Catheter Cardiovasc Interv 84:416\u2013425","journal-title":"Catheter Cardiovasc Interv"},{"key":"2438_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s00395-021-00859-7","volume":"116","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Wernly B, Cao X, Mustafa SJ, Tang Y, Zhou Z (2021) Adenosine and adenosine receptor-mediated action in coronary microcirculation. Basic Res Cardiol 116:22","journal-title":"Basic Res Cardiol"},{"key":"2438_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150021","volume":"11","author":"MF Ho","year":"2016","unstructured":"Ho MF, Low LM, Rose\u2019Meyer RB (2016) Pharmacology of the adenosine A3 receptor in the vasculature and essential hypertension. PLoS ONE 11:e0150021","journal-title":"PLoS ONE"},{"key":"2438_CR12","doi-asserted-by":"publisher","first-page":"683","DOI":"10.3181\/0812-RM-350","volume":"234","author":"SB Bender","year":"2009","unstructured":"Bender SB, Tune JD, Borbouse L, Long X, Sturek M, Laughlin MH (2009) Altered mechanism of adenosine-induced coronary arteriolar dilation in early-stage metabolic syndrome. Exp Biol Med (Maywood) 234:683\u2013692","journal-title":"Exp Biol Med (Maywood)"},{"key":"2438_CR13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.phrs.2013.08.007","volume":"77","author":"Z Zhou","year":"2013","unstructured":"Zhou Z, de Wijs-Meijler D, Lankhuizen I, Jankowski J, Jankowski V, Jan Danser AH, Duncker DJ, Merkus D (2013) Blunted coronary vasodilator response to uridine adenosine tetraphosphate in post-infarct remodeled myocardium is due to reduced P1 receptor activation. Pharmacol Res 77:22\u201329","journal-title":"Pharmacol Res"},{"key":"2438_CR14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1161\/01.CIR.104.2.157","volume":"104","author":"B De Bruyne","year":"2001","unstructured":"De Bruyne B, Pijls NH, Bartunek J, Kulecki K, Bech JW, De Winter H, Van Crombrugge P, Heyndrickx GR, Wijns W (2001) Fractional flow reserve in patients with prior myocardial infarction. Circulation 104:157\u2013162","journal-title":"Circulation"},{"key":"2438_CR15","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/BF03085982","volume":"15","author":"MJ Kofflard","year":"2007","unstructured":"Kofflard MJ, Michels M, Krams R, Kliffen M, Geleijnse ML, Ten Cate FJ, Serruys PW (2007) Coronary flow reserve in hypertrophic cardiomyopathy: relation with microvascular dysfunction and pathophysiological characteristics. Neth Heart J 15:209\u2013215","journal-title":"Neth Heart J"},{"key":"2438_CR16","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1093\/eurheartj\/eht040","volume":"34","author":"HJ Jang","year":"2013","unstructured":"Jang HJ, Koo BK, Lee HS, Park JB, Kim JH, Seo MK, Yang HM, Park KW, Nam CW, Doh JH, Kim HS (2013) Safety and efficacy of a novel hyperaemic agent, intracoronary nicorandil, for invasive physiological assessments in the cardiac catheterization laboratory. Eur Heart J 34:2055\u20132062","journal-title":"Eur Heart J"},{"key":"2438_CR17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/clc.22344","volume":"38","author":"N Tanaka","year":"2015","unstructured":"Tanaka N, Takahashi Y, Ishihara H, Kawakami T, Ono H (2015) Usefulness and safety of intracoronary administration of nicorandil for evaluating fractional flow reserve in Japanese patients. Clin Cardiol 38:20\u201324","journal-title":"Clin Cardiol"},{"key":"2438_CR18","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00380-014-0508-5","volume":"30","author":"D Kato","year":"2015","unstructured":"Kato D, Takashima H, Waseda K, Kurita A, Kuroda Y, Kosaka T, Kuhara Y, Ando H, Maeda K, Kumagai S, Sakurai S, Suzuki A, Toda Y, Watanabe A, Sato S, Fujimoto M, Mizuno T, Amano T (2015) Feasibility and safety of intracoronary nicorandil infusion as a novel hyperemic agent for fractional flow reserve measurements. Heart Vessel 30:477\u2013483","journal-title":"Heart Vessel"},{"key":"2438_CR19","doi-asserted-by":"publisher","first-page":"955","DOI":"10.2165\/00003495-200060040-00007","volume":"60","author":"A Markham","year":"2000","unstructured":"Markham A, Plosker GL, Goa KL (2000) Nicorandil. an updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects. Drugs 60:955\u2013974","journal-title":"Drugs"},{"key":"2438_CR20","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1253\/circj.CJ-19-0421","volume":"83","author":"K Ishibuchi","year":"2019","unstructured":"Ishibuchi K, Fujii K, Otsuji S, Takiuchi S, Hasegawa K, Tamaru H, Ishii R, Yasuda S, Nakabayashi S, Yamamoto W, Kusumoto H, Taniguchi Y, Kakishita M, Shimatani Y, Higashino Y (2019) Utility and validity of intracoronary administration of nicorandil alone for the measurement of fractional flow reserve in patients with intermediate coronary stenosis. Circ J 83:2010\u20132016","journal-title":"Circ J"},{"key":"2438_CR21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jjcc.2016.01.018","volume":"69","author":"H Takami","year":"2017","unstructured":"Takami H, Sonoda S, Muraoka Y, Sanuki Y, Kashiyama K, Fukuda S, Oginosawa Y, Tsuda Y, Araki M, Otsuji Y (2017) Impact of additional intracoronary nicorandil administration during fractional flow reserve measurement with intravenous adenosine 5\u2019-triphosphate infusion. J Cardiol 69:119\u2013124","journal-title":"J Cardiol"},{"key":"2438_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijcard.2020.05.013","volume":"314","author":"H Matsumoto","year":"2020","unstructured":"Matsumoto H, Mikuri M, Masaki R, Tanaka H, Ogura K, Arai T, Sakai R, Oishi Y, Okada N, Shinke T (2020) Feasibility of intracoronary nicorandil for inducing hyperemia on fractional flow reserve measurement: comparison with intracoronary papaverine. Int J Cardiol 314:1\u20136","journal-title":"Int J Cardiol"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-024-02438-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00380-024-02438-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-024-02438-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T15:07:14Z","timestamp":1736435234000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00380-024-02438-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,9]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["2438"],"URL":"https:\/\/doi.org\/10.1007\/s00380-024-02438-x","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,9]]},"assertion":[{"value":"11 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This manuscript has been read and approved by all the authors, the requirements for authorship as stated above have been met, and each author believes that this manuscript represents honest work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authorship inclusion criteria"}}]}}